What the structures published from 2018 showed about how IGF-1 binds and activates its receptor

Published 26 October 2026 · REVIVE LAB UAE Research Desk · 5 min read
Cryo-electron microscopy structures of the full extracellular IGF-1 receptor in complex with IGF-1, reported from 2018 onward, showed a single IGF-1 molecule bound asymmetrically at the junction between the two alpha subunits, contacting the first leucine-rich domain of one protomer and the carboxyl-terminal region of the alpha chain of the other. Binding converts the receptor from an inverted-V resting shape to a compact T shape, bringing the membrane-proximal regions and therefore the intracellular kinase domains close enough to phosphorylate each other. The structures resolved long-standing questions about stoichiometry and mechanism in the insulin receptor family.

What was seen

The resting receptor holds its two halves apart in an inverted V, stabilised by contacts that keep the kinases separated. IGF-1 inserts at the apex, bridging elements from both halves. The receptor collapses inward and the legs come together. The ligand sits in a site composed of both protomers, which is why it is a dimer-spanning interaction rather than two independent sites.

Comparable structures of the insulin receptor showed a related but distinct mode with up to four insulins bound.

What it settled

That one IGF-1 is sufficient to activate the receptor; that the alpha-chain carboxyl-terminal segment is a true part of the binding site; and that activation is a large-scale rearrangement rather than a subtle local change. These had been inferred biochemically for decades and were now visible.

The structures also showed where IGF-1 LR3 would differ: the extension sits at the amino terminus, away from the receptor contacts, consistent with its modest effect on receptor affinity.

Why it matters here

The receptor is what the molecule in the pack acts on, and the structures are the current picture of that interaction. This page describes them.

IGF-1 LR3 is supplied by REVIVE LAB UAE for laboratory research use only, with identity and purity documented for the batch. It is not for human or veterinary use, and no dosing, administration or protocol guidance is provided.

What it costs

FormatStrengthPriceAvailability
IGF-1 LR3 Pack1 mgAED 650In stock

Delivery is AED 40 flat and free on orders over AED 700. Payment is cash on delivery anywhere in the UAE, or USDT (TRC20) in advance, which takes 5% off the order total.

Frequently asked

What was seen?

The resting receptor holds its two halves apart in an inverted V, stabilised by contacts that keep the kinases separated. IGF-1 inserts at the apex, bridging elements from both halves. The receptor collapses inward and the legs come together. The ligand sits in a site composed of both protomers, which is why it is a dimer-spanning interaction rather than two independent sites.

Does REVIVE LAB UAE provide dosing guidance?

No. REVIVE LAB UAE supplies research materials and provides no dosing, administration or protocol guidance of any kind. Every product is sold for laboratory research use only and is not for human or veterinary consumption.

How fast is delivery in the UAE?

Stock is held in Dubai. An order confirmed before 4 PM Dubai time is dispatched the same working day, reaching Dubai and Abu Dhabi the same day and the remaining emirates within 24 hours. Delivery is AED 40 flat and free over AED 700.

IGF-1 LR3 Pack — in stock, dispatched from Dubai
HPLC-verified, lot certificate on every carton, 24-hour delivery nationwide. Browse the catalogue → All peptides UAE

Related reading

Supplied for laboratory research use only. Not for human or veterinary consumption. REVIVE LAB UAE provides no dosing, administration or protocol guidance.